Search research articles
Contact Us
Filters
Showing results (41-50 of 134) with videos related to
Page
of 14
Sort By:
The New England Journal of Medicine
|
September 7, 2022
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
Panke Qu, Julia N Faraone, John P Evans, et al.
Leukemia & Lymphoma
|
February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study
Gerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia & Lymphoma
|
March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
American Journal of Hematology
|
February 22, 2023
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis
Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, et al.
Plos One
|
April 3, 2010
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity
Andrzej T Slominski, Zorica Janjetovic, Brian E Fuller, et al.
Blood Advances
|
February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Blood
|
January 17, 2004
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions
Gerard Lozanski, Nyla A Heerema, Ian W Flinn, et al.
JCI Insight
|
October 9, 2020
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors
Cong Zeng, John P Evans, Rebecca Pearson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 15, 2020
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay
Cong Zeng, John P Evans, Rebecca Pearson, et al.
Haematologica
|
October 30, 2020
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 134) with videos related to
Sort By:
Page
of 14
The New England Journal of Medicine
|
September 7, 2022
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
Panke Qu, Julia N Faraone, John P Evans, et al.
Leukemia & Lymphoma
|
February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study
Gerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia & Lymphoma
|
March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
American Journal of Hematology
|
February 22, 2023
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis
Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, et al.
Plos One
|
April 3, 2010
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity
Andrzej T Slominski, Zorica Janjetovic, Brian E Fuller, et al.
Blood Advances
|
February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Blood
|
January 17, 2004
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions
Gerard Lozanski, Nyla A Heerema, Ian W Flinn, et al.
JCI Insight
|
October 9, 2020
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors
Cong Zeng, John P Evans, Rebecca Pearson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 15, 2020
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay
Cong Zeng, John P Evans, Rebecca Pearson, et al.
Haematologica
|
October 30, 2020
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, et al.
Page
of 14